Rigel Pharmaceuticals Inc (RIGL)
Equity Ratio
81.64%
Quarterly · Period ending:
RIGL Equity Ratio
Latest reported81.64%period ending
Latest reported81.64%period ending
RIGL Quarterly Equity Ratio (76.27% → 81.64%)
Latest values, visible window
High-resolution chart · PNG
RIGL equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 81.6446% | |
| 79.249% | |
| 76.2236% | |
| 48.4918% | |
| 39.6322% | |
| 10.5511% | |
| 2.0052% | |
| -10.4979% | |
| -23.2961% | |
| -25.0326% | |
| -24.4351% | |
| -27.604% | |
| -24.0112% | |
| -19.6235% | |
| -10.1401% | |
| -17.1561% | |
| -2.8726% | |
| 4.5602% | |
| 18.1524% | |
| 26.6301% | |
| 33.7851% | |
| 36.2502% | |
| 30.8268% | |
| 41.4073% | |
| 45.7927% | |
| 54.7554% | |
| 36.4677% | |
| 44.1565% | |
| 50.1358% | |
| 55.1643% | |
| 78.9863% | |
| 84.009% | |
| 87.5003% | |
| 80.7657% | |
| 84.4977% | |
| 78.8309% | |
| 81.4303% | |
| 82.9807% | |
| 70.4264% | |
| 74.3933% | |
| 74.2247% | |
| 69.6823% | |
| 69.361% | |
| 69.2721% | |
| 68.1826% | |
| 67.6858% | |
| 83.2037% | |
| 89.9711% | |
| 90.847% | |
| 92.6396% | |
| 92.1228% | |
| 93.2641% | |
| 93.6474% | |
| 93.7697% | |
| 93.2438% | |
| 89.9586% | |
| 91.3183% | |
| 92.5908% | |
| 91.8489% | |
| 93.511% | |
| 94.0725% | |
| 90.1267% | |
| 88.9852% | |
| 88.9952% | |
| 63.5154% | |
| 42.7295% | |
| 78.0616% | |
| 79.3134% | |
| 58.4371% | |
| 67.5004% | |
| 72.4082% | |
| 77.5551% | |
| 83.3202% | |
| 86.9665% | |
| 70.9757% | |
| 78.8067% | |
| 82.1865% | |
| 74.7329% | |
| 77.0302% | |
| 79.9452% | |
| 80.2391% | |
| 74.9527% | |
| 73.5352% | |
| 76.3717% | |
| 49.7698% | |
| 55.7245% | |
| 66.3533% | |
| 76.709% | |
| 81.1605% | |
| 84.4943% | |
| 71.9923% | |
| 76.3058% | |
| 77.6924% | |
| 53.501% | |
| 57.3745% | |
| 60.5933% | |
| 66.4575% | |
| 70.423% | |
| 62.3084% | |
| 64.887% |